AstraZeneca Diabetes Drug Given FDA Approval for Children

AstraZeneca Diabetes Drug Given FDA Approval for Children

AstraZeneca has been granted FDA approval for its once-weekly diabetes medicine Bydureon (exenatide) to treat children (aged 10-18) with type-2 diabetes. The drug, an injectable suspension, aims to lower blood sugar rates. The approval is based on a late-stage study...